Filed before 2025Filed 4 June 2024
IconOVir Bio, Inc. has sold $20.2M so far
IconOVir Bio, Inc., a biotech company based in New York, NY, has sold $20.2M so far in its debt round, according to a filing dated 4 June 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 4 June 2024
- First filed
- 21 June 2023
- Round
- Debt round (amended filing)
- Amount sold
- $20.2M
- Offering size
- $20.2M
- Investors so far
- 34
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 75% of the 1,434 tracked raises with an amount filed in 2024, and than 53% of the 138 in biotech.
IconOVir Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 4 Jun 2024 | Amended filing | $20.2M | This raise |
| 21 Jun 2023 | New filing | $20.2M | This raise |
| 14 Dec 2020 | New filing | $77M | Another raise |
More with Vida Ventures on the board
- MeridianMade, Inc.$20.3M
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Quanta Therapeutics, Inc.$76.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.